Zurich Cantonal Bank’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,174
Closed -$38K 2924
2021
Q3
$38K Hold
4,174
﹤0.01% 2695
2021
Q2
$47K Hold
4,174
﹤0.01% 2463
2021
Q1
$44K Hold
4,174
﹤0.01% 2425
2020
Q4
$45K Hold
4,174
﹤0.01% 2461
2020
Q3
$41K Hold
4,174
﹤0.01% 2310
2020
Q2
$33K Hold
4,174
﹤0.01% 2334
2020
Q1
$36K Buy
4,174
+3,541
+559% +$36.8K ﹤0.01% 2091
2019
Q4
$7K Hold
633
﹤0.01% 2582
2019
Q3
$7K Hold
633
﹤0.01% 2582
2019
Q2
$6K Hold
633
﹤0.01% 2592
2019
Q1
$8K Hold
633
﹤0.01% 2530
2018
Q4
$7K Hold
633
﹤0.01% 2560
2018
Q3
$9K Hold
633
﹤0.01% 2549
2018
Q2
$9K Hold
633
﹤0.01% 2500
2018
Q1
$8K Hold
633
﹤0.01% 2507
2017
Q4
$8K Hold
633
﹤0.01% 2511
2017
Q3
$8K Hold
633
﹤0.01% 2452
2017
Q2
$9K Hold
633
﹤0.01% 2443
2017
Q1
$8K Hold
633
﹤0.01% 2510
2016
Q4
$9K Hold
633
﹤0.01% 2471
2016
Q3
$8K Hold
633
﹤0.01% 2453
2016
Q2
$7K Hold
633
﹤0.01% 2456
2016
Q1
$7K Hold
633
﹤0.01% 2459
2015
Q4
$7K Hold
633
﹤0.01% 2476
2015
Q3
$7K Hold
633
﹤0.01% 2285
2015
Q2
$9K Hold
633
﹤0.01% 1450
2015
Q1
$9K Buy
+633
New +$8.75K ﹤0.01% 1432

Other funds holding LFCR

Zurich Cantonal Bank's LFCR Position: Q4 2021 in Review

Zurich Cantonal Bank sold out of Lifecore Biomedical (LFCR) in Q4 2021, closing a stake of 4,174 shares — an estimated $38K sold.

Zurich Cantonal Bank first reported a position in LFCR in Q1 2015 and held it in 27 quarters. The position peaked at $47K in Q2 2021. 98 funds tracked by Wall St. Rank hold LFCR as of Q4 2021.

  • Zurich Cantonal Bank reported no remaining Lifecore Biomedical position as of Q4 2021 after selling out during the quarter.
  • Zurich Cantonal Bank sold 4,174 Lifecore Biomedical shares in Q4 2021, an estimated $38K.
  • Zurich Cantonal Bank first reported a position in Lifecore Biomedical in Q1 2015 and held it in 27 quarters.
  • Zurich Cantonal Bank's Lifecore Biomedical position peaked at $47K in Q2 2021.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2021.

Based on Zurich Cantonal Bank's 13F filing for Q4 2021, filed 1 Feb 2022.